Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab. (Q46572209)
Jump to navigation
Jump to search
scientific article published on 7 November 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab. |
scientific article published on 7 November 2013 |
Statements
1 reference
Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab (English)
Michelle Fanale
Andres Forero
Mehdi Hamadani
Thomas Kipps
Antonio Cuneo
Douglas Gladstone
Marc Andre
Naresh Bellam
Trishna Goswami
Ramy Ibrahim
Amy Schneider
Meina Liang
Steven Eck
Nairouz Elgeioushi
7 November 2013
1 reference
1 November 2013
1 reference